Stay updated on Immuno-Therapy BMS-986178 in Solid Cancers Clinical Trial
Sign up to get notified when there's something new on the Immuno-Therapy BMS-986178 in Solid Cancers Clinical Trial page.

Latest updates to the Immuno-Therapy BMS-986178 in Solid Cancers Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0; the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check8 days agoChange DetectedA sitewide notice says NIH is transitioning to use “Super Intelligence” instead of “Artificial Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check15 days agoChange DetectedThe ClinicalTrials.gov page continues to display a 403 Forbidden error. Its footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check22 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, indicating that access to the content is restricted and only a basic header/footer is shown.SummaryDifference23%

- Check64 days agoChange DetectedThe page revision label updated from v3.6.5 to v3.6.6, indicating a new release of the page's metadata. This is an administrative change and does not modify study content or functionality.SummaryDifference0.0%

Stay in the know with updates to Immuno-Therapy BMS-986178 in Solid Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immuno-Therapy BMS-986178 in Solid Cancers Clinical Trial page.